Table 5 Impact of subtype change and gain in receptor status on survival
Patient Details | Total | Change subtype | Gain of Receptor |
|---|---|---|---|
(n = 132) | (n = 31) 23.5% | (n = 9) 6.8% | |
Survival: Months | N (%) | N (%) | N (%) |
Overall: mean (SD ±) | 60 (38.3) | 64.9 (40.3) | 76.9 (56.3) |
Post-recurrence survival: mean (SD ±) | 20.7 (21.1) | 18.5 (22.8) | 30.6 (30.3) |